RA Capital Management »

Editas Medicine shares owned by RA Capital Management

Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Editas Medicine

Tip: Access up to 7 years of quarterly data

All positions including Editas Medicine held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Editas Medicine by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $29M 8.9M 3.24

More positions owned by RA Capital Management

Ascendis Pharma A/s Common Stock (ASND)
Parabilis Medicines Common Stock
Rhythm Pharmaceuticals Common Stock (RYTM)
Vaxcyte Common Stock (PCVX)
Sionna Therapeutics Common Stock (SION)
Tyra Biosciences Common Stock (TYRA)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Hemab Therapeutics Holdings Common Stock
Septerna Common Stock (SEPN)
Bicara Therapeutics Common Stock (BCAX)
Mineralys Therapeutics Common Stock (MLYS)
Gh Research Common Stock (GHRS)
Disc Medicine Common Stock (IRON)
Spyglass Pharma Common Stock (SGP)

View all positions for RA Capital Management

Top funds holding Editas Medicine

BlackRock
ADAR1 Capital Management
RA Capital Management
Vanguard Capital Management
Vanguard Portfolio Management
Goldman Sachs Group
Renaissance Technologies
Geode Capital Management
State Street Corporation
Marshall Wace
Nuveen
Opaleye Management
D. E. Shaw & Co
Jpmorgan Chase & Co
Two Sigma Investments

View all funds holding Editas Medicine